Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Kim Cheema"'
Autor:
Ann Elaine Clarke, Kim Cheema, Adrian Boucher, Francesca S Cardwell, Susan J Elliott, Megan R W Barber, Sydney George
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 2 (2024)
Objective Lupus nephritis (LN) is a major cause of morbidity and mortality, affecting up to 60% of patients with systemic lupus erythematosus (SLE). The perspectives of patients with SLE have been explored; however, little is known of the lived exper
Externí odkaz:
https://doaj.org/article/714ba0ebde4e45c79341dd98653ac3f2
Autor:
Ann Elaine Clarke, Kim Cheema, Adrian Boucher, Francesca S Cardwell, Susan J Elliott, Megan R W Barber, Sydney George
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss 2 (2023)
Objective Lupus nephritis (LN) is one of the most severe manifestations of SLE; however, we know little about the lived experience of LN. This research investigates patient experiences and perspectives of (1) LN diagnosis; (2) living with LN; and (3)
Externí odkaz:
https://doaj.org/article/2f0978f330324160aba18c448267f6b9
Autor:
Mark D. Elliott, Leslie C. James, Emily L. Simms, Priyana Sharma, Louis P. Girard, Kim Cheema, Meghan J. Elliott, Julie L. Lauzon, Justin Chun
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 8 (2021)
Purpose: Genetic testing results are currently obtained approximately 1 year after referral to a medical genetics team for autosomal dominant polycystic kidney disease (ADPKD). We evaluated a mainstream genetic testing (MGT) pathway whereby the nephr
Externí odkaz:
https://doaj.org/article/9f209c404d6f4968a1ee042da422103f
Autor:
Dimitrios T Boumpas, Antonis Fanouriakis, George Bertsias, David Jayne, Myrto Kostopoulou, Kim Cheema, John Boletis
Publikováno v:
RMD Open, Vol 6, Iss 2 (2020)
Objectives To analyse the current evidence for the management of lupus nephritis (LN) informing the 2019 update of the EULAR/European Renal Association-European Dialysis and Transplant Association recommendations.Methods According to the EULAR standa
Externí odkaz:
https://doaj.org/article/1eb0f8a36f984b0d9eb4f3e7dba5e193
Autor:
Jane Lemaire, Adam Papini, Shannon M. Ruzycki, Kelly B. Zarnke, Parabhdeep Lail, Stephanie Smith, Paul MacMullan, Kim Cheema, Kerri A. Johannson, Paul S. Gibson, Wendy Desjardins-Kallar, Irene W. Y. Ma, Meghan E O Vlasschaert, Angela Hunter, Meghan J. Elliott, Jeffrey P Schaefer, Gabriel Fabreau, Brendan Kerr, Nimira Alimohamed, Rahim Kachra, Evan P. Minty, Sachin R. Pendharkar, Caley B. Shukalek, Aleem Bharwani, Thomas Allen
Publikováno v:
Journal of General Internal Medicine
Background The evolving COVID-19 pandemic has and continues to present a threat to health system capacity. Rapidly expanding an existing acute care physician workforce is critical to pandemic response planning in large urban academic health systems.
Publikováno v:
Rheumatology. 60:iii67-iii69
Autor:
Leslie C. James, Meghan J. Elliott, Louis Girard, Emily Lauren Simms, Mark Elliott, Kim Cheema, Justin Chun, Julie Lauzon, Priyana Sharma
Publikováno v:
Canadian Journal of Kidney Health and Disease
Canadian Journal of Kidney Health and Disease, Vol 8 (2021)
Canadian Journal of Kidney Health and Disease, Vol 8 (2021)
Genetic testing results are currently obtained approximately 1 year after referral to a medical genetics team for autosomal dominant polycystic kidney disease (ADPKD). We evaluated a mainstream genetic testing (MGT) pathway whereby the nephrology tea
Publikováno v:
Rheumatology (Oxford, England). 60(Suppl 3)
Autor:
Bernadette Van Leew, Gabriella Moroni, Hans-Joachim Anders, Stephen D. Marks, Ingeborg M. Bajema, Josef S Smolen, Myrto Kostopoulou, Ioannis Parodis, George Bertsias, Y K Onno Teng, Frédéric Houssiau, A E Voskuyl, Maria Trachana, Martin Aringer, David Jayne, Antonis Fanouriakis, Ronald F van Vollenhoven, A. Karras, Matthias Schneider, Eleni Frangou, Dimitrios T. Boumpas, Manuel Praga, Francesca Marchiori, John Boletis, Kim Cheema, Marta Mosca, Jane L Hollis, Vladimir Tesar
Publikováno v:
Annals of the rheumatic diseases, 79(6):216924, S713-S723. BMJ Publishing Group
Annals of the Rheumatic Diseases, 79(6), S713-S723. BMJ Publishing Group
Fanouriakis, A, Kostopoulou, M, Cheema, K, Anders, H J, Aringer, M, Bajema, I, Boletis, J, Frangou, E, Houssiau, F A, Hollis, J, Karras, A, Marchiori, F, Marks, S D, Moroni, G, Mosca, M, Parodis, I, Praga, M, Schneider, M, Smolen, J S, Tesar, V, Trachana, M, Van Vollenhoven, R F, Voskuyl, A E, Teng, Y K O, Van Leew, B, Bertsias, G, Jayne, D & Boumpas, D T 2020, ' 2019 Update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis ', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. S713-S723 . https://doi.org/10.1136/annrheumdis-2020-216924
Annals of the Rheumatic Diseases, 79(6), 713-723. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 79(6), S713-S723. BMJ Publishing Group
Fanouriakis, A, Kostopoulou, M, Cheema, K, Anders, H J, Aringer, M, Bajema, I, Boletis, J, Frangou, E, Houssiau, F A, Hollis, J, Karras, A, Marchiori, F, Marks, S D, Moroni, G, Mosca, M, Parodis, I, Praga, M, Schneider, M, Smolen, J S, Tesar, V, Trachana, M, Van Vollenhoven, R F, Voskuyl, A E, Teng, Y K O, Van Leew, B, Bertsias, G, Jayne, D & Boumpas, D T 2020, ' 2019 Update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis ', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. S713-S723 . https://doi.org/10.1136/annrheumdis-2020-216924
Annals of the Rheumatic Diseases, 79(6), 713-723. BMJ PUBLISHING GROUP
Funder: European League Against Rheumatism; FundRef: http://dx.doi.org/10.13039/501100008741
Objective: To update the 2012 EULAR/ERA–EDTA recommendations for the management of lupus nephritis (LN). Methods: Following the EULAR standardised ope
Objective: To update the 2012 EULAR/ERA–EDTA recommendations for the management of lupus nephritis (LN). Methods: Following the EULAR standardised ope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84179148130b922a9f01be88134d24b6
https://doi.org/10.1136/annrheumdis-2020-216924
https://doi.org/10.1136/annrheumdis-2020-216924
Autor:
Kim Cheema, George Bertsias, Antonis Fanouriakis, John Boletis, David Jayne, Dimitrios T. Boumpas, Myrto Kostopoulou
Publikováno v:
RMD Open
RMD Open, Vol 6, Iss 2 (2020)
RMD Open, Vol 6, Iss 2 (2020)
ObjectivesTo analyse the current evidence for the management of lupus nephritis (LN) informing the 2019 update of the EULAR/European Renal Association-European Dialysis and Transplant Association recommendations.MethodsAccording to the EULAR standard